OneBlood Donor App is a health utility for scheduling blood donations and accessing screening history on iOS and Android.
Product velocity
Maintenance
Daily rank 🇺🇸
—
Health & Fitness
Sentiment
2.3
359 reviews
Nemesis
MySejahtera
The App DNA
What makes this app unique?
Donors hire this app to manage their donation cadence and review personal health metrics, but the current technical friction forces users to seek alternatives for reliable health tracking.
For Existing and prospective blood donors managing donation schedules and personal health metrics.
What does it look like?
Key features
Direct booking interface for blood donation slots.
Access to personal health metrics like cholesterol and blood pressure.
How much does it cost?
The app functions as a non-monetized utility for donor management.
Velocity
Maintenance developmentperformanceUX improvementsShow more...
The app exhibits a very low release cadence, with only two updates recorded over the last six months, averaging approximately 0.08 releases per week. Both the latest release and the preceding version focus exclusively on performance, stability, and library updates, indicating a maintenance-focused development cycle. There is no evidence of new feature development or live operations. The development trend is stable at a low-frequency maintenance level.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads frustrated. Users report technical instability and booking friction.
How are ratings & reviews evolving?
What users say, by theme
- Technical instability and booking friction
Competition
Competitive landscape for OneBlood Donor App
How's the Health & Fitness market?
OneBlood maintains a niche utility position in the Health & Fitness category, but its 2.18 average rating across 359 total ratings indicates a failure to retain users compared to broader health platforms.
Read the market outlookThe rivals identified
By JABATAN DIGITAL NEGARA (JDN)
MySejahtera serves as a massive, government-backed digital health ecosystem that overlaps with OneBlood’s goal of managing personal health records and donation-related medical history.
- Massive government-mandated user base creates an insurmountable network effect for health record management.
- Integrated vaccination and national healthcare services provide utility far beyond simple blood donation tracking.
- High-frequency updates and massive scale ensure it remains the primary health portal for millions.
Unlock the head-to-head verdict: where this rival wins, and where it loses.
Access the full report for freeThe Analyst's Read
Key takeaways for OneBlood Donor App
Where is it heading?
Users report: The health utility market is consolidating around platforms that offer seamless data integration, leaving OneBlood exposed due to its static, maintenance-mode posture. Continued technical friction will likely drive donors to seek alternative health-management apps for their screening data, reducing the app's role to a simple, low-engagement booking tool.
- Persistent technical instability in the latest release erodes user trust, which compounds the rating drag already visible on iOS.
The SWOT
- Direct integration with blood center scheduling [standard utility]
- Native Apple Health integration [competitor gap]
Next best moves
Rebuild appointment booking flow because booking friction is the primary churn driver → increase successful donation rate
The counter-intuitive read
The app's primary risk is not a lack of features…
Read the full takeFeature gaps
Native Apple Health integration (available in Corpusmetra but absent here) +1
Since the last report: The competitive landscape has expanded to include government-backed health platforms, and the app's positioning has shifted to reflect declining iOS performance and a pivot toward booking stability.
Bottom line
OneBlood fails to provide a stable donor experience, because technical friction in the booking flow erodes user trust, so the PM must prioritize stability over new feature development to prevent donor churn.
Unlock 2 critical frictions, 1 market threat and the analyst’s take.
Access the full report for freeReport last updated